Current Trends in Pharmacy and Pharmaceutical Chemistry

Online ISSN: 2582-5062

Current Trends in Pharmacy and Pharmaceutical Chemistry is the official Journal of Ateos Foundation of Science Education and Research, hosted and Managed IP Innovative Publications Pvt. Ltd, New Delhi, India. Current Trends in Pharmacy and Pharmaceutical Chemistry is an open access, peer-reviewed quarterly international journal publishing since 2019 and is published under auspices of the Ateos Foundation of Science Education and Research. It aims to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. more...

  • Article highlights
  • Article tables
  • Article images

Article statistics

Viewed: 764

PDF Downloaded: 561


Get Permission Nerkar and Chakraborthy: Niosomes


Introduction

Niosomes are a novel drug delivery system, which trap the hydrophilic drug in the middle cavity and hydrophobic drugs into the non-polar area present within the bilayer hence equally hydrophilic and hydrophobic drugs can be integrated into niosomes.1

For various decades, medication of an severe disease or a chronic sickness have been capable by delivering drugs to the patients passing through diverse pharmaceutical quantity forms like tablets, capsules, pills, creams, ointments, liquids, aerosol, injectables and suppositories as carrier. To achieve and then to maintain the absorption of medicine administered surrounded by the therapeutically useful collection essential for medication, it is often essential to obtain this type of drug delivery systems.2

The concept targeted drug delivery is intended for attempting to focus the drug in the tissues of while reducing the qualified concentration of the medication in the outstanding tissues. As a result, drug is confined to a small area on the targeted site.3

Niosomes are encapsulated in vehicles. The active agent surfactant is composed non-ionic bilayer. It is very important system in vascular structure of escapsulated drug, and reduce the toxicity. It is the different type of preparation of method. Niosomes are Structurally related to liposomes and also are equiactive in drug delivery future but high chemical strength make niosomes advanced than liposomes. Equally consist of bilayer, which is ended in non-ionic surfactant in the folder of niosomes and phospholipids in case of liposomes. Niosomes are atomic lamellar structure of size range between 10 to 1000 nm and consists of environmental, non-immunogenic and biocompatible surfactants.4

Salient features of niosomes

  1. Noisomes can easily dissolve.

  2. Niosomes are surrounding lively and stable.

  3. Niosomes is comprising of hydrophobic and hydrophilic intrastructure.

  4. The medication atoms with an extensive diversity of dissolvability.

  5. The stability of niosomes increase the entrapped medicine.5

Advantages

  1. Oral bioavailability is improved for the poorly soluble drugs.

  2. The condition are the medication limiting is target cell

  3. The medicine increases absorption of the properly applied to the skin

  4. The medicine is commonly used to non-aqueous type

  5. The surfactant used and also the prepare niosomes are biocompatible and biodegradable.

  6. A condition is required in handling and storage of surfactants.

  7. Its administration in different type of routes ex:- topical, inhalation intravenous intradermal etc

  8. They made to reach for the site of action in oral, parenteral as well as current route.6

Figure 1
https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/b3ccb18d-155c-450c-a32a-f3ef35a2168eimage1.png

Comparison of niosomes

Figure 2

Niosome.

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/b3ccb18d-155c-450c-a32a-f3ef35a2168eimage2.png

Structure of niosome

The vascular system is similar to liposome that can be used as carriers of amphiphilic and lipophilic drug. The action of les is improve the toxic drug in restricting by the cell.

Types of niosomes

  1. Bola surfactant containing niosomes: The natural of the compound of ammonium glycyrrhizinate and active drug usually an anti-inflammatory agent.

  2. Vesicles in water and oil system (v/w/o): In aqueous stage of niosomes from vesicle in water in oil emulsion. Niosomes set can be expansion of sorbitol monosterate and cholesterol. This result in vesicle in oil and water emulsion, and cool to the rom temperature in water and oil.

  3. Deformable niosomes: These smaller vesicles can easily pass through the pores of stratum corneum, causing increase penetration efficiency. It is used in the topical preparation.5, 6, 7, 8

Component of niosomes

For the readiness of niosomes, two major components are utilised that is cholesterol and non-ionic surfactant. The following instrument is used for the preparation of niososmes.9, 10, 11

Figure 3

Probe-sonicator

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/b3ccb18d-155c-450c-a32a-f3ef35a2168eimage3.png

Non-ionic surfactants

Niosomes are non-ionic surfactant unilamellar or multilamellar vesicles formed from synthetic non-ionic surfactants.12

Charged inducers

Positive charge inducer and negative charge inducer are the two types of charge inducer.

Characterization of niosomes

Nonionic surfactant based on novel drug delivery systems is from self assembly of nonionic amphiphiles in aqueous media. The characterization of a niosomal formulation of the glucose-derivative N-palmitoylglucosamine are

Material and Methods13

Light scattering and transmission electron microscopy.

  1. Vesicle caracterization

  2. Homogeneity and zeta potential

  3. Drug department efficiency

  4. In terms of mean size

  5. Size exclusion chromatography

Conclusion

Niosomes is studied as an substitute to liposomes. Niosomal drug delivery system is one of the examples in the great progression in drug delivery technology. The idea of drug inclusion in the niosomes and target to the niosomes. The exact site is commonly accepted by researchers and academicians. Advantages in excess of the liposomes make it a recovered targeting agent, to the area of achievement for healthier efficiency.

Source of Funding

None.

Conflict of Interest

None.

References

1 

S Gandhi D Shakya K Ranjan S Bansal Corneal ulcer: A prospective clinical and microbiological studyInt J Med Sci Public Health20143111334710.5455/ijmsph.2014.030820142

2 

P Y Chien A timing stabilized laser diode based range simulatorMeas Sci Technol199125478910.1088/0957-0233/2/5/011

3 

T M Allen Liposomal drug formulationsDrugs199856574756

4 

R M H Vila A. Ribier B. Rondot G. Vanlerberge Dispersions of lamellar phases of non-ionic lipids in cosmetic productsInt J Cosmet Sci1979153031410.1111/j.1467-2494.1979.tb00224.x

5 

K B Makeshwar S R Wasankar Niosome: a novel drug delivery systemAsian J Pharm Res201331162010.5958/2231–5691

6 

A Bagheri B S Chu H Yaakob Niosomal drug delivery systems: formulation, preparation and applicationsWorld Appl Sci J20143216718510.5829/idosi.wasj.2014.32.08.848

7 

A Gandhi S O Sen A Paul Current Trends In Niosome As Vesicular Drug Delivery SystemAsian J Pharm Life Sci ISSN20122233953

8 

A K Verma J C Bindal Vital role of niosomes on controlled novel drug delivery systemIndian J Novel Drug Deliv Syst2011323846

9 

G Amoabediny F Haghiralsadat S Naderinezhad M N Helder E A Kharanaghi J M Arough Overview of preparation methods of polymeric and lipid-based (niosome, solid lipid, liposome) nanoparticles: A comprehensive reviewInt J Polymeric Mater Polymeric Biomater201867638340010.1080/00914037.2017.1332623

10 

A Sankhyan P Pawar Recent trends in niosome as vesicular drug deliveryJ Appl Pharm Sci201226203210.7324/JAPS.2012.2625

11 

P Tangri S Khurana Niosomes: formulation and evaluationInt J Biopharmaceutics2011214753

12 

M Bragagni N Mennini C Ghelardini P Mura Development and Characterization of Niosomal Formulations of Doxorubicin Aimed at Brain TargetingJ Pharm Pharm Sci201215118410.18433/j3230m

13 

H Abdelkader A W G Alani R G Alany Recent advances in non-ionic surfactant vesicles (niosomes): self-assembly, fabrication, characterization, drug delivery applications and limitationsDrug Deliv20142128710010.3109/10717544.2013.838077



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Article type

Short Communication


Article page

28-30


Authors Details

A. G. Nerkar, G. S. Chakraborthy


Article History

Received : 26-05-2021

Accepted : 21-07-2021


Article Metrics


View Article As

 


Downlaod Files